Abstract

NOSH-aspirin (NBS-1120) inhibits estrogen receptor negative breast cancer<i>in vitro</i>and i<i>n vivo</i>by modulating redox-sensitive signaling pathways

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.